Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2026-01-18 @ 4:40 AM
Study NCT ID:
NCT01208961
Status:
COMPLETED
Last Update Posted:
2015-07-15
First Post:
2010-09-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OM-EPA-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |